HeartWare International, Inc. (HeartWare) is a medical device company developing a family of implantable Left Ventricular Assist Devices ("LVADs") for the treatment of advanced heart failure. The Company is listed on both the Nasdaq Stock Market and the Australian Securities Exchange (ASX). HeartWare common shares trade on Nasdaq under the symbol "HTWR". HeartWare CDIs (Chess Depository Interests) trade on ASX under the symbol "HIN". Each common share on Nasdaq is equivalent to 35 CDIs on ASX.